Sifting through countless of stocks in the Health Care Equipment & Supplies industry can be tedious, and sometimes two stocks are just too similar to judge which is the better investment. If you’re on ...

All right. Good morning, everyone, and welcome to Masimo's 2025 Investor Day. I'm Matt Brinckman. I recently joined Masimo as Senior Vice President of FP&A and Investor Relations. I've been working ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long ...

Masimo (NASDAQ: MASI) today hosted its 2025 Investor Day at the Company’s headquarters. At the event, Masimo’s management team provided an update on the Company’s long-term strategy, including the ...

Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Apple has suffered a major defeat in its long-term legal dispute with the medtech firm Masimo and has been ordered to pay $634 million in damages. As the Daily Journal reports, a federal jury agreed ...

Amid its multifront legal battle with Apple over its smartwatch’s blood oxygen sensors, Masimo has claimed new ground—including a significant patent infringement verdict in federal court, plus the ...

What just happened? Apple has been dealt a blow in its long-running patent battle against Masimo after a court ordered Cupertino to pay the health tech firm $634 million. The decision came on the same ...

A federal jury in California has ruled that Apple Inc. (NASDAQ: AAPL) must pay Masimo Corporation (NASDAQ: MASI) $634 million for infringing a patent related to blood-oxygen reading technology. The ...

In the latest chapter of the long-running legal war between Apple and medical tech company Masimo, a federal jury in California has ordered Apple to pay $634 million in damages. The jury found that ...

A federal jury in California has found that Apple infringed on a Masimo patent for its pulse oximetry technology and awarded Masimo $634 million in damages, Masimo said Friday. “This is a significant ...